In the BioHarmony Drug Report Database
Alprazolam
Niravam, Xanax (alprazolam) is a small molecule pharmaceutical. Alprazolam was first approved as Niravam on 1982-01-01. It is used to treat agoraphobia, depressive disorder, and panic disorder in the USA. It is known to target gamma-aminobutyric acid receptor subunit alpha-3, gamma-aminobutyric acid receptor subunit alpha-5, gamma-aminobutyric acid receptor subunit alpha-1, gamma-aminobutyric acid receptor subunit alpha-2, and bromodomain-containing protein 4.
Trade Name
|
Niravam, Xanax |
|---|---|
Common Name
|
alprazolam |
ChEMBL ID
|
CHEMBL661 |
Indication
|
agoraphobia, depressive disorder, panic disorder |
Drug Class
|
Benzodiazepine |
Image (chem structure or protein)